What hantaviruses are
Hantaviruses are zoonotic viruses naturally maintained in rodent reservoirs. Human disease is uncommon, but some infections progress quickly and can be fatal.
Information hantavirus et signaux d'alerte
HantaVirus2026
A concise medical knowledge base for hantavirus transmission, symptoms, prevention, official outbreak updates, and first-step risk triage.
How people are exposed
Most infection occurs after contact with contaminated rodent urine, droppings, saliva, nesting material, or dust from enclosed spaces with rodent activity.
Clinical syndromes
In the Americas, severe disease is usually hantavirus cardiopulmonary syndrome. In Europe and Asia, many pathogenic hantaviruses cause hemorrhagic fever with renal syndrome.
Person-to-person spread
Human-to-human transmission is not typical for most hantaviruses. Limited close-contact transmission has been documented for Andes virus, mainly in South America.
Hantavirus compared with COVID-19
Primary reservoir
- Hantavirus
- Rodents; each virus is usually linked to specific reservoir species.
- COVID-19
- Humans are the major reservoir during ongoing transmission.
Common transmission
- Hantavirus
- Environmental exposure to rodent excreta or contaminated dust; bites are less common.
- COVID-19
- Respiratory particles and close contact between people.
Human-to-human spread
- Hantavirus
- Uncommon; documented mainly for Andes virus with close, prolonged contact.
- COVID-19
- Common, including presymptomatic and asymptomatic transmission.
Incubation
- Hantavirus
- Usually 1 to 8 weeks depending on virus and exposure context.
- COVID-19
- Usually days, commonly within the first week after exposure.
Early symptoms
- Hantavirus
- Fever, headache, muscle aches, fatigue, abdominal pain, nausea, vomiting, diarrhea.
- COVID-19
- Fever, cough, sore throat, fatigue, headache, congestion, loss of taste or smell in some cases.
Severe disease pattern
- Hantavirus
- Rapid respiratory failure, shock, or kidney and bleeding complications depending on syndrome.
- COVID-19
- Pneumonia, hypoxemia, thrombotic complications, inflammatory disease, and long-term sequelae.
Diagnosis
- Hantavirus
- Serology for IgM or rising IgG, RT-PCR in acute illness, and exposure history.
- COVID-19
- PCR, antigen testing, and clinical context.
Treatment
- Hantavirus
- No licensed specific cure; early supportive care and ICU-level monitoring can improve survival.
- COVID-19
- Supportive care plus antivirals or immunomodulators in selected patients.
Prevention
- Hantavirus
- Rodent exclusion, safe cleaning, ventilation, wet disinfection, and avoiding dry sweeping.
- COVID-19
- Vaccination, ventilation, masking in high-risk settings, testing, and isolation when infectious.